Citius Pharmaceuticals to Present at the ThinkEquity Conference

Wednesday, May 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CRANFORD, N.J., May 1, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 8:30AM ET.

The conference is being held at The Mandarin Oriental Hotel in New York City.

During the conference, Executive Chairman, Mr. Leonard Mazur will be giving the presentation as well as answering questions from investors. Citius Pharmaceuticals recently raised $5.3 million with 37% from coming from Mr. Leonard Mazur, Executive Chairman of Citius Pharmaceuticals and Mr. Myron Holubiak, President and CEO of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. will also be available for one-on-one meetings. To arrange a meeting with the Company, please contact Mr. Andrew Scott: ascott@citiuspharma.com.

About Citius Pharmaceuticals, Inc.Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously-approved active pharmaceutical ingredients. We seek to achieve leading market positions by providing therapeutic products that address unmet medical needs; by using previously approved drugs with substantial safety and efficacy data, we seek to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, please visit www.citiuspharma.com.

Contact:Andrew Scott                                                               Vice President, Corporate Development                                                        (o) 908-967-6677ascott@citiuspharma.com 

Cision View original content:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-present-at-the-thinkequity-conference-300841248.html

SOURCE Citius Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store